Aptilon announces financial results for fiscal year 2013

MONTREAL, May 2, 2014 /CNW/ - On April 30, 2014,Aptilon Corporation ("Aptilon" or the "Company") (NEX: APZ.H), filed its financial statements and MD&A for the year ended December 31, 2013 reporting a net income of $4.4 million on revenues of $17.3 million. Net income for the year includes a gain on extinguishment of debt of $3.6 million following the renegotiation of a portion of its long term debt during the 4th quarter of 2013.

During the year ended December 31, 2012, the Company incurred a net loss of $4.8 million on revenues of $15.4 million. In 2012, net income included a net loss from discontinued operations of $3.0 million.

The Company reported an operating income, before net finance expense, gain on extinguishment of debt and earnings from discontinued operations, of $2.2 million for the year ended December 31, 2013 compared to an operating income, before foreign exchange, interest and loss from discontinued operations, of $1.5 million for the year ended December 31, 2012.

For the three months ended December 31, 2013, the Company reported a net income of $6.2 million on revenues of $4.7 million compared to a net loss of $1.8 million on revenues of $4 million for the three months ended December 31, 2012.  Net income for the quarter ended December 31, 2013 includes a gain on extinguishment of debt of $3.6 million following the renegotiation of a portion of its long term debt during the quarter.  For the three month period ended December 31, 2012, net income included a net loss from discontinued operations of $1.4 million.

The Company reported an operating income, before net finance expense, gain on extinguishment of debt and earnings from discontinued operations of $1.1 million for the quarter ended December 31, 2013 compared with an operating income, before foreign exchange, interest and loss from discontinued operations of $0.7 million for the quarter ended December 31, 2012.

The successful refinancing realized in the 4th quarter of 2013 will enable the Company to focus its energy towards improving and expanding its data services product.

Complete financial statements and MD&A for the year ended December 31, 2013 are available on SEDAR at www.sedar.com

About Aptilon Corporation
Aptilon enables pharmaceutical, pharmaceutical marketing companies, digital advertising agencies and medical device companies to effectively reach, message, connect and interact with US physicians and healthcare professionals via multiple access channels. Its innovative service offerings provide targeted impressions and interactions through permission-based email, targeted on-line ad-serving, and mobile app advertising channels. Top pharmaceutical companies, agencies and respected healthcare organizations have adopted Aptilon's solutions to target, engage and interact with leading healthcare practitioners. For more information, visit www.dmdconnects.com .

Forward-looking statements
This news release contains forward-looking information. These statements relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management of Aptilon. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and Aptilon does not assume any obligation to update or revise them to reflect new events or circumstances.

Neither NEX, the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Aptilon Corporation

For further information: André Charron, CFO, Aptilon Corporation, 514-769-5858, ACharron@dmdconnects.com